Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Indo Straits Tbk. (PTIS) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Indo Straits Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Indo Straits Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Indo Straits Tbk. trades at Rp270 (market cap 149.64B, 147.4K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 147.4K). Which is the better fit depends on your goals.

OBATPTIS
Market Cap
172.82B149.64B
Volume
592.2K147.4K
Lot
5.92K1.47K
Turnover
147.05M39.56M
Average Price
248.31268.4
Value
147.05M39.56M
Indicative Equilibrium Price
254270
Indicative Equilibrium Volume
1071

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
PTIS
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Indo Straits Tbk.

PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.

Read more on PTIS